Based on the Cancer or Tumor Profiling market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Cancer or Tumor Profiling market covered in Chapter 5:
Caris Life Sciences
Genomic Health
Ribomed Biotechnologies Inc.
Neogenomics Inc
Helomics Corporation
Oxford Gene Technology
GenomeDX
Foundation Medicine
HTG Molecular Diagnostics, Inc.
Illumina Inc.
Qiagen N.V.
Guardant Health
Nanostring Technologies
In Chapter 6, on the basis of types, the Cancer or Tumor Profiling market from 2015 to 2025 is primarily split into:
Immunoassays
Hybridization
Next-Generation Sequencing
Mass Spectrometry
Other technologies
In Chapter 7, on the basis of applications, the Cancer or Tumor Profiling market from 2015 to 2025 covers:
Clinical Application
Research Applications
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Cancer or Tumor Profiling Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Caris Life Sciences
5.1.1 Caris Life Sciences Company Profile
5.1.2 Caris Life Sciences Business Overview
5.1.3 Caris Life Sciences Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Caris Life Sciences Cancer or Tumor Profiling Products Introduction
5.2 Genomic Health
5.2.1 Genomic Health Company Profile
5.2.2 Genomic Health Business Overview
5.2.3 Genomic Health Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Genomic Health Cancer or Tumor Profiling Products Introduction
5.3 Ribomed Biotechnologies Inc.
5.3.1 Ribomed Biotechnologies Inc. Company Profile
5.3.2 Ribomed Biotechnologies Inc. Business Overview
5.3.3 Ribomed Biotechnologies Inc. Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Ribomed Biotechnologies Inc. Cancer or Tumor Profiling Products Introduction
5.4 Neogenomics Inc
5.4.1 Neogenomics Inc Company Profile
5.4.2 Neogenomics Inc Business Overview
5.4.3 Neogenomics Inc Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Neogenomics Inc Cancer or Tumor Profiling Products Introduction
5.5 Helomics Corporation
5.5.1 Helomics Corporation Company Profile
5.5.2 Helomics Corporation Business Overview
5.5.3 Helomics Corporation Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Helomics Corporation Cancer or Tumor Profiling Products Introduction
5.6 Oxford Gene Technology
5.6.1 Oxford Gene Technology Company Profile
5.6.2 Oxford Gene Technology Business Overview
5.6.3 Oxford Gene Technology Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Oxford Gene Technology Cancer or Tumor Profiling Products Introduction
5.7 GenomeDX
5.7.1 GenomeDX Company Profile
5.7.2 GenomeDX Business Overview
5.7.3 GenomeDX Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 GenomeDX Cancer or Tumor Profiling Products Introduction
5.8 Foundation Medicine
5.8.1 Foundation Medicine Company Profile
5.8.2 Foundation Medicine Business Overview
5.8.3 Foundation Medicine Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Foundation Medicine Cancer or Tumor Profiling Products Introduction
5.9 HTG Molecular Diagnostics, Inc.
5.9.1 HTG Molecular Diagnostics, Inc. Company Profile
5.9.2 HTG Molecular Diagnostics, Inc. Business Overview
5.9.3 HTG Molecular Diagnostics, Inc. Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 HTG Molecular Diagnostics, Inc. Cancer or Tumor Profiling Products Introduction
5.10 Illumina Inc.
5.10.1 Illumina Inc. Company Profile
5.10.2 Illumina Inc. Business Overview
5.10.3 Illumina Inc. Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Illumina Inc. Cancer or Tumor Profiling Products Introduction
5.11 Qiagen N.V.
5.11.1 Qiagen N.V. Company Profile
5.11.2 Qiagen N.V. Business Overview
5.11.3 Qiagen N.V. Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Qiagen N.V. Cancer or Tumor Profiling Products Introduction
5.12 Guardant Health
5.12.1 Guardant Health Company Profile
5.12.2 Guardant Health Business Overview
5.12.3 Guardant Health Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Guardant Health Cancer or Tumor Profiling Products Introduction
5.13 Nanostring Technologies
5.13.1 Nanostring Technologies Company Profile
5.13.2 Nanostring Technologies Business Overview
5.13.3 Nanostring Technologies Cancer or Tumor Profiling Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Nanostring Technologies Cancer or Tumor Profiling Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Cancer or Tumor Profiling Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Cancer or Tumor Profiling Sales and Market Share by Types (2015-2020)
6.1.2 Global Cancer or Tumor Profiling Revenue and Market Share by Types (2015-2020)
6.1.3 Global Cancer or Tumor Profiling Price by Types (2015-2020)
6.2 Global Cancer or Tumor Profiling Market Forecast by Types (2020-2025)
6.2.1 Global Cancer or Tumor Profiling Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Cancer or Tumor Profiling Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Cancer or Tumor Profiling Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Cancer or Tumor Profiling Sales, Price and Growth Rate of Immunoassays
6.3.2 Global Cancer or Tumor Profiling Sales, Price and Growth Rate of Hybridization
6.3.3 Global Cancer or Tumor Profiling Sales, Price and Growth Rate of Next-Generation Sequencing
6.3.4 Global Cancer or Tumor Profiling Sales, Price and Growth Rate of Mass Spectrometry
6.3.5 Global Cancer or Tumor Profiling Sales, Price and Growth Rate of Other technologies
6.4 Global Cancer or Tumor Profiling Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Immunoassays Market Revenue and Sales Forecast (2020-2025)
6.4.2 Hybridization Market Revenue and Sales Forecast (2020-2025)
6.4.3 Next-Generation Sequencing Market Revenue and Sales Forecast (2020-2025)
6.4.4 Mass Spectrometry Market Revenue and Sales Forecast (2020-2025)
6.4.5 Other technologies Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Cancer or Tumor Profiling Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Cancer or Tumor Profiling Sales and Market Share by Applications (2015-2020)
7.1.2 Global Cancer or Tumor Profiling Revenue and Market Share by Applications (2015-2020)
7.2 Global Cancer or Tumor Profiling Market Forecast by Applications (2020-2025)
7.2.1 Global Cancer or Tumor Profiling Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Cancer or Tumor Profiling Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Cancer or Tumor Profiling Revenue, Sales and Growth Rate of Clinical Application (2015-2020)
7.3.2 Global Cancer or Tumor Profiling Revenue, Sales and Growth Rate of Research Applications (2015-2020)
7.4 Global Cancer or Tumor Profiling Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Clinical Application Market Revenue and Sales Forecast (2020-2025)
7.4.2 Research Applications Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Cancer or Tumor Profiling Sales by Regions (2015-2020)
8.2 Global Cancer or Tumor Profiling Market Revenue by Regions (2015-2020)
8.3 Global Cancer or Tumor Profiling Market Forecast by Regions (2020-2025)
9 North America Cancer or Tumor Profiling Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Cancer or Tumor Profiling Market Sales and Growth Rate (2015-2020)
9.3 North America Cancer or Tumor Profiling Market Revenue and Growth Rate (2015-2020)
9.4 North America Cancer or Tumor Profiling Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Cancer or Tumor Profiling Market Analysis by Country
9.6.1 U.S. Cancer or Tumor Profiling Sales and Growth Rate
9.6.2 Canada Cancer or Tumor Profiling Sales and Growth Rate
9.6.3 Mexico Cancer or Tumor Profiling Sales and Growth Rate
10 Europe Cancer or Tumor Profiling Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Cancer or Tumor Profiling Market Sales and Growth Rate (2015-2020)
10.3 Europe Cancer or Tumor Profiling Market Revenue and Growth Rate (2015-2020)
10.4 Europe Cancer or Tumor Profiling Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Cancer or Tumor Profiling Market Analysis by Country
10.6.1 Germany Cancer or Tumor Profiling Sales and Growth Rate
10.6.2 United Kingdom Cancer or Tumor Profiling Sales and Growth Rate
10.6.3 France Cancer or Tumor Profiling Sales and Growth Rate
10.6.4 Italy Cancer or Tumor Profiling Sales and Growth Rate
10.6.5 Spain Cancer or Tumor Profiling Sales and Growth Rate
10.6.6 Russia Cancer or Tumor Profiling Sales and Growth Rate
11 Asia-Pacific Cancer or Tumor Profiling Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Cancer or Tumor Profiling Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Cancer or Tumor Profiling Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Cancer or Tumor Profiling Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Cancer or Tumor Profiling Market Analysis by Country
11.6.1 China Cancer or Tumor Profiling Sales and Growth Rate
11.6.2 Japan Cancer or Tumor Profiling Sales and Growth Rate
11.6.3 South Korea Cancer or Tumor Profiling Sales and Growth Rate
11.6.4 Australia Cancer or Tumor Profiling Sales and Growth Rate
11.6.5 India Cancer or Tumor Profiling Sales and Growth Rate
12 South America Cancer or Tumor Profiling Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Cancer or Tumor Profiling Market Sales and Growth Rate (2015-2020)
12.3 South America Cancer or Tumor Profiling Market Revenue and Growth Rate (2015-2020)
12.4 South America Cancer or Tumor Profiling Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Cancer or Tumor Profiling Market Analysis by Country
12.6.1 Brazil Cancer or Tumor Profiling Sales and Growth Rate
12.6.2 Argentina Cancer or Tumor Profiling Sales and Growth Rate
12.6.3 Columbia Cancer or Tumor Profiling Sales and Growth Rate
13 Middle East and Africa Cancer or Tumor Profiling Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Cancer or Tumor Profiling Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Cancer or Tumor Profiling Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Cancer or Tumor Profiling Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Cancer or Tumor Profiling Market Analysis by Country
13.6.1 UAE Cancer or Tumor Profiling Sales and Growth Rate
13.6.2 Egypt Cancer or Tumor Profiling Sales and Growth Rate
13.6.3 South Africa Cancer or Tumor Profiling Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Cancer or Tumor Profiling Market Size and Growth Rate 2015-2025
Table Cancer or Tumor Profiling Key Market Segments
Figure Global Cancer or Tumor Profiling Market Revenue ($) Segment by Type from 2015-2020
Figure Global Cancer or Tumor Profiling Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Cancer or Tumor Profiling
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Caris Life Sciences Company Profile
Table Caris Life Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Caris Life Sciences Production and Growth Rate
Figure Caris Life Sciences Market Revenue ($) Market Share 2015-2020
Table Genomic Health Company Profile
Table Genomic Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genomic Health Production and Growth Rate
Figure Genomic Health Market Revenue ($) Market Share 2015-2020
Table Ribomed Biotechnologies Inc. Company Profile
Table Ribomed Biotechnologies Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ribomed Biotechnologies Inc. Production and Growth Rate
Figure Ribomed Biotechnologies Inc. Market Revenue ($) Market Share 2015-2020
Table Neogenomics Inc Company Profile
Table Neogenomics Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Summary: Get latest Market Research Reports on Cancer or Tumor Profiling. Industry analysis & Market Report on Cancer or Tumor Profiling is a syndicated market report, published as Global Cancer or Tumor Profiling Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Cancer or Tumor Profiling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.